Sarepta Therapeutics (SRPT) Change in Intangibles (2010 - 2026)
Sarepta Therapeutics' quarterly Change in Intangibles came in at $1.0 million in Q1 2026, down 55.32% year-on-year from $2.2 million in Q1 2025, and up 112.92% quarter-over-quarter from -$7.7 million in Q4 2025.
Sarepta Therapeutics has reported Change in Intangibles for 17 years, with the latest figure at $1.0 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Intangibles fell 55.32% year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at -$1.2 million (up 84.05% YoY), and the FY2023 full-year result was $102.0 million, up 7047.86% from the prior year.
- Change in Intangibles for Q1 2026 stood at $1.0 million, up from -$7.7 million in the prior quarter.
- The five-year high for Change in Intangibles was $101.9 million in Q3 2023, with the low at -$10.0 million in Q4 2024.
- Average Change in Intangibles over 5 years is $9.5 million, with a median of $1.0 million recorded in 2026.
- Year-over-year, Change in Intangibles jumped 10538.3% in 2024 and slumped 77.62% in 2025.
- Tracing SRPT's Change in Intangibles over 5 years: stood at $1.4 million in 2022, then soared by 7038.12% to $101.9 million in 2023, then slumped by 109.82% to -$10.0 million in 2024, then gained by 22.62% to -$7.7 million in 2025, then jumped by 112.92% to $1.0 million in 2026.
- The last three Change in Intangibles figures came in at $1.0 million (Q1 2026), -$7.7 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 1.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | -7.74 Mn |
| Dec 31, 2025 | -7.74 Mn |
| Sep 30, 2025 | 5.31 Mn |
| Sep 30, 2025 | 5.31 Mn |
| Jun 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 188,000.00 |
| Mar 31, 2025 | 2.24 Mn |
| Mar 31, 2025 | 2.24 Mn |
| Dec 31, 2024 | -10.00 Mn |
| Dec 31, 2024 | -10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Mar 31, 2024 | 10.00 Mn |
| Sep 30, 2023 | 101.86 Mn |
| Sep 30, 2023 | 101.86 Mn |
| Jun 30, 2023 | 45,000.00 |
| Jun 30, 2023 | 45,000.00 |
| Mar 31, 2023 | 94,000.00 |
| Mar 31, 2023 | 94,000.00 |
| Dec 31, 2022 | 1.43 Mn |
| Dec 31, 2022 | 1.43 Mn |
| Dec 31, 2021 | -99.69 Mn |
| Dec 31, 2021 | -99.69 Mn |
| Mar 31, 2020 | 108.07 Mn |
| Mar 31, 2020 | 108.07 Mn |
| Dec 31, 2019 | 1.03 Mn |
| Dec 31, 2019 | 1.03 Mn |
| Sep 30, 2019 | 594,000.00 |
| Sep 30, 2019 | 594,000.00 |
| Jun 30, 2019 | 599,000.00 |
| Jun 30, 2019 | 599,000.00 |
| Mar 31, 2019 | 855,000.00 |
| Mar 31, 2019 | 855,000.00 |
| Dec 31, 2018 | 555,000.00 |
| Dec 31, 2018 | 555,000.00 |
| Sep 30, 2018 | 1.08 Mn |
| Sep 30, 2018 | 1.08 Mn |
| Jun 30, 2018 | 883,000.00 |
| Jun 30, 2018 | 883,000.00 |
| Mar 31, 2018 | 673,000.00 |
| Mar 31, 2018 | 673,000.00 |
| Sep 30, 2017 | 123.40 Mn |
| Sep 30, 2017 | 123.40 Mn |
| Jun 30, 2017 | -123.40 Mn |
| Jun 30, 2017 | -123.40 Mn |
| Mar 31, 2017 | 125.00 Mn |
| Mar 31, 2017 | 125.00 Mn |
| Dec 31, 2016 | 432,000.00 |
| Dec 31, 2016 | 432,000.00 |
| Sep 30, 2016 | 325,000.00 |
| Sep 30, 2016 | 325,000.00 |
| Jun 30, 2016 | 358,000.00 |
| Jun 30, 2016 | 358,000.00 |
| Mar 31, 2016 | 410,000.00 |
| Mar 31, 2016 | 410,000.00 |
| Dec 31, 2015 | 450,000.00 |
| Dec 31, 2015 | 450,000.00 |
| Sep 30, 2015 | 342,000.00 |
| Sep 30, 2015 | 342,000.00 |
| Jun 30, 2015 | 249,000.00 |
| Jun 30, 2015 | 249,000.00 |
| Mar 31, 2015 | 391,000.00 |
| Mar 31, 2015 | 391,000.00 |
| Dec 31, 2014 | 319,000.00 |
| Dec 31, 2014 | 319,000.00 |
| Sep 30, 2014 | 434,000.00 |
| Sep 30, 2014 | 434,000.00 |
| Jun 30, 2014 | 334,000.00 |
| Jun 30, 2014 | 334,000.00 |
| Mar 31, 2014 | 294,000.00 |
| Mar 31, 2014 | 294,000.00 |
| Dec 31, 2013 | 124,000.00 |
| Dec 31, 2013 | 124,000.00 |
| Sep 30, 2013 | 350,000.00 |
| Sep 30, 2013 | 350,000.00 |
| Jun 30, 2013 | 470,000.00 |
| Jun 30, 2013 | 470,000.00 |
| Mar 31, 2013 | 461,000.00 |
| Mar 31, 2013 | 461,000.00 |
| Dec 31, 2012 | 423,000.00 |
| Dec 31, 2012 | 423,000.00 |
| Sep 30, 2012 | 116,000.00 |
| Sep 30, 2012 | 116,000.00 |
| Jun 30, 2012 | 245,000.00 |
| Jun 30, 2012 | 245,000.00 |
| Mar 31, 2012 | 253,000.00 |
| Mar 31, 2012 | 253,000.00 |
| Dec 31, 2011 | 579,000.00 |
| Dec 31, 2011 | 579,000.00 |
| Sep 30, 2011 | 23,000.00 |
| Sep 30, 2011 | 23,000.00 |
| Jun 30, 2011 | 416,000.00 |
| Jun 30, 2011 | 416,000.00 |
| Mar 31, 2011 | 109,000.00 |
| Mar 31, 2011 | 109,000.00 |
| Dec 31, 2010 | 301,000.00 |
| Dec 31, 2010 | 301,000.00 |
| Sep 30, 2010 | 199,000.00 |
| Sep 30, 2010 | 199,000.00 |